SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-012557
Filing Date
2023-04-12
Accepted
2023-04-12 16:06:59
Documents
12
Period of Report
2023-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K impl-20230412.htm   iXBRL 8-K 70836
  Complete submission text file 0000950170-23-012557.txt   204483

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT impl-20230412_pre.xml EX-101.PRE 12029
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT impl-20230412.xsd EX-101.SCH 2459
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT impl-20230412_lab.xml EX-101.LAB 18452
6 EXTRACTED XBRL INSTANCE DOCUMENT impl-20230412_htm.xml XML 5106
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 8-K | Act: 34 | File No.: 001-40353 | Film No.: 23815753
SIC: 2834 Pharmaceutical Preparations